M11.059
Hydroxyapatite deposition disease, unspecified hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Hydroxyapatite deposition disease (HADD) is a condition characterized by the accumulation of tiny crystals of a mineral called hydroxyapatite in or around the joints. When it affects the hip, it can cause pain and inflammation, impacting mobility and quality of life. The ICD-10 code M11.059 specifically refers to an unspecified case of hydroxyapatite deposition disease in the hip, indicating that the exact location or severity of the condition has not been detailed.
Causes & Symptoms
Clinical Causes: Degenerative changes in the joints leading to abnormal mineral deposits Repeated trauma or injury to the hip area Aging process, which may promote mineral buildup Genetic predisposition or familial tendency Localized tissue inflammation or degeneration Previous joint or soft tissue injuries increases susceptibility
Key Symptoms: Localized hip pain that worsens with movement or activity Swelling and tenderness around the hip joint Reduced range of motion in the affected hip Stiffness, especially after periods of inactivity Possible muscle weakness around the hip Discomfort that may radiate to the thigh or groin
Diagnostic & Treatment
Diagnosis Path: Diagnosis of hydroxyapatite deposition disease involves a combination of patient history, physical examination, and imaging studies. Imaging techniques such as X-rays can reveal calcified deposits characteristic of HADD in the hip area. Advanced imaging like ultrasound or MRI may provide more detailed insights into the extent of the mineral deposits and surrounding tissue involvement. Blood tests are typically not useful for diagnosing HADD but may be performed to rule out other conditions.
Treatment Protocols: Managing hydroxyapatite deposition disease generally focuses on alleviating symptoms and reducing inflammation. Common strategies include: - Rest and activity modifications to reduce joint stress - NSAIDs (non-steroidal anti-inflammatory drugs) to decrease pain and inflammation - Physical therapy exercises to improve joint flexibility and strength - Corticosteroid injections in cases of significant inflammation - Supportive devices such as crutches or hip braces for mobility - In rare cases, surgical removal of calcified deposits may be recommended if conservative treatments fail and symptoms persist It is important to consult healthcare professionals for tailored management plans based on individual circumstances.
Clinical Advice & FAQs
Billing Guidance
Is M11.059 a billable ICD-10 code?
Yes, M11.059 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.059?
Clinical documentation must specify the nature of Hydroxyapatite deposition disease, unspecified hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
